Venezuela uses distressed bonds to settle debts with drugmakers
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/24/2026
- Nasdaq, S&P end lower as tech stocks fall
- Micron posts record profit as AI memory demand fuels explosive growth
- Brent settles at lowest since before start of Iran war as more tankers exit Hormuz
- All eyes on Micron earnings tonight as sell-off raises stakes for AI memory trade
- Alphabet added to Dow Jones Industrial Average, Verizon dropped
- Needham Starts NeoVolta (NEOV) at Buy
- Wall Street ends lower on semiconductor selloff as AI spending concerns mount
- NextEra to discuss paying about $76 per share for Dominion, Bloomberg News reports
- Campbell Soup (CPB) Declares $0.39 Quarterly Dividend; 7.7% Yield
- UBS Reiterates Buy Rating on Snowflake Inc. (SNOW)
Jefferies Cuts Price Target on Pfizer (PFE) to $42; Reiterates Buy
March 8, 2016 8:41 AM ESTJefferies maintained a Buy rating on Pfizer (NYSE: PFE), and cut the price target to $42.00 (from $45.00). Jefferies updated their model following the Form S-4 filing for certain LOE assumptions, as well as some fine-tuning on stand-alone operating costs and tax rate assumptions in the... More
